about
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cellsLATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progressionThe anaphase-promoting complex/cyclosome activator Cdh1 modulates Rho GTPase by targeting p190 RhoGAP for degradation.Features of ovarian cancer in Lynch syndrome (Review).Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancer.Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by EpigeneticsBiomarkers in endometrial cancer: Possible clinical applications (Review)MicroRNA and endometrial cancer: Roles of small RNAs in human tumors and clinical applications (Review).Mevalonate Pathway Antagonist Suppresses Formation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models.ARID1A gene mutation in ovarian and endometrial cancers (Review).Relationship of lower uterine segment cancer with Lynch syndrome: a novel case with an hMLH1 germline mutationInactivating ARID1A Tumor Suppressor Enhances TERT Transcription and Maintains Telomere Length in Cancer Cells.Candidate biomarkers for genetic and clinicopathological diagnosis of endometrial cancerEndometrial cancer as a familial tumor: pathology and molecular carcinogenesis (review).Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis.Current status of molecular-targeted drugs for endometrial cancer (Review).Gene expression signatures of primary and metastatic uterine leiomyosarcoma.Narrow band imaging in gynecology: a new diagnostic approach with improved visual identification (Review).Gene expression profile of a newly established choriocarcinoma cell line, iC3-1, compared to existing choriocarcinoma cell lines and normal placenta.A tumor of the uterine cervix with a complex histology in a Peutz-Jeghers syndrome patient with genomic deletion of the STK11 exon 1 region.New use of microsatellite instability analysis in endometrial cancer.Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model.Aurora kinase inhibitors: Potential molecular-targeted drugs for gynecologic malignant tumors.Drug repositioning of mevalonate pathway inhibitors as antitumor agents for ovarian cancer.Indocyanine green fluorescence imaging in the pregnant cynomolgus macaque: childbearing is supported by a unilateral uterine artery and vein alone?Analysis of candidate target genes for mononucleotide repeat mutation in microsatellite instability-high (MSI-H) endometrial cancer.SIM2l attenuates resistance to hypoxia and tumor growth by transcriptional suppression of HIF1A in uterine cervical squamous cell carcinoma.Recent findings on epigenetic gene abnormalities involved in uterine cancer.Cost-effectiveness of surveillance and prevention strategies in BRCA1/2 mutation carriers.Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer.Radiation-induced angiosarcoma of the omentum diagnosed by laparoscopy: A case report.Erratum: Recent advances in the molecular mechanisms of Mayer-Rokitansky-Küster-Hauser syndrome.Preoperative and intraoperative assessment of myometrial invasion in endometrial cancer: comparison of magnetic resonance imaging and frozen sections.IFPA Meeting 2012 Workshop Report III: trophoblast deportation, gestational trophoblastic disease, placental insufficiency and fetal growth restriction, trophoblast over-invasion and accreta-related pathologies, placental thrombosis and fibrinolysisCarcinoma of the lower uterine segment diagnosed with Lynch syndrome based on MSH6 germline mutation: A case report.Flexible hysteroscopy with narrow band imaging (NBI) for endoscopic diagnosis of malignant endometrial lesions.Drug repositioning for gynecologic tumors: a new therapeutic strategy for cancer.Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.
P50
Q28271164-1480D34D-7293-49CC-90A0-E2425EF200E9Q30522305-CDF69A91-4350-4A42-A2FC-259695C667E9Q34045733-9D3C0555-1027-479E-9D07-1230EA4CEB21Q34265940-C565E7C9-4597-41FE-8915-8DFB0CB6DFA8Q35167913-DC494E56-1A57-492B-B926-2023524A50C1Q35168142-85F8A59C-D14D-47CB-BE70-04A0B6BE3631Q35882785-B0B1D1B3-020A-42CB-9749-3FFB75C2E1ACQ36084326-257213F6-D0FA-488C-8D3D-4F169B86C892Q36142558-84FD5D37-8106-4830-A01B-4F5609AB0BF9Q36172482-75843E9F-4056-4FD2-9506-B9E20D44C6FAQ36399463-879D7078-0DAB-4F31-B11A-F6F9F5FA22DFQ36642662-F264DDDF-D7C5-41AE-8D50-574DF32A68EDQ36850060-BA7C81D4-A571-4803-97DC-A1CA6C806D1AQ37007297-CB5A00A1-5EA7-4B55-B7E7-8975528EA292Q37236178-1E80B33A-7EDD-413F-A46C-D607045A2021Q37269300-1C1AE574-AE04-4752-9616-7B012581CED8Q37373629-573B678A-2B11-4882-917F-5E4FA0D9B3A9Q37560813-CC3A4836-CDAE-4187-BB45-6067CFA394ECQ37662836-7E07619E-3451-43DD-9E42-8504D39AAFAAQ37945032-0280C2EC-0143-4A45-893F-4590C97518CBQ39235168-C3646205-1489-47DB-A407-319AFB055EF3Q39257685-4F0564A9-E685-481B-92A5-51182950BFBDQ41619058-6A7ACEB3-4F64-4386-BF62-336075CFE2B6Q41853906-5DBD2E4E-927A-4C4D-9279-F37A41CF9CE5Q42562915-3B0589AD-B7A3-47E9-9CDE-96DDB6C01ADBQ42654023-523320C9-9605-48CA-B9C0-E1C9FC92773AQ43571207-8258DCBB-01C2-4C4D-B7FA-4BF47E30781AQ46576145-A9E5279A-3A15-47B5-A31E-45BFCF1ABF2DQ47150172-B8E54114-B8F2-413D-AD05-C4FCCC573C9CQ47153989-4D0CBD70-8313-47C4-AFAF-3EA9CCF5CDB2Q47246829-C27FA8A2-2558-4488-9145-B7AB2A37BD34Q48107196-C574601F-9E57-4F64-8E92-9E7F26C15A34Q49236188-DF93FE05-5F40-4948-A5C9-02DE12D89814Q49333952-157A4634-0A66-478F-B38E-F6F95A81F521Q50895673-7D8DE12D-F93E-452A-A751-C6648C1127F4Q51201499-8D778D17-4E00-4EEE-AD55-003FF0AC5C60Q51280079-2F606B5E-877E-4353-8277-AC64BE5ADA7FQ51612698-DA698007-FB61-472C-BAFF-BDF1C645BCCDQ52962540-60B0326F-C166-4B8D-9049-575BEC9816D9Q52981291-358A7CEA-2EF0-4EC8-A186-040A1D40A676
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yusuke Kobayashi
@ast
Yusuke Kobayashi
@en
Yusuke Kobayashi
@es
Yusuke Kobayashi
@nl
type
label
Yusuke Kobayashi
@ast
Yusuke Kobayashi
@en
Yusuke Kobayashi
@es
Yusuke Kobayashi
@nl
prefLabel
Yusuke Kobayashi
@ast
Yusuke Kobayashi
@en
Yusuke Kobayashi
@es
Yusuke Kobayashi
@nl
P106
P31
P496
0000-0002-4503-2845